Today: 30 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

Ecolab shares traded near 52-week highs on December 1, 2025, closing at $272.86 after reporting Q3 earnings with 13% EPS growth and revenue of $4.17 billion. The company launched new AI and water-focused products and maintains a market cap near $78 billion. Ecolab’s dividend yield stands at about 0.9–1.0%. The stock outperformed the broader materials sector and key peers over the past year.
U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp closed at $49.41 on December 1, 2025, after reporting record Q3 revenue of $7.33 billion and net income of $2 billion, both above analyst expectations. The stock yields about 4.2% and has outperformed regional bank peers over the past three months. Shares remain below year-ago levels and face ongoing scrutiny over insider sales and regulatory risks.
General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

General Dynamics shares closed at $332.38 on December 1, down 2.71% but up 26% year-to-date. The company reported three straight quarters of double-digit earnings growth in 2025 and ended Q2 with a record $88.7 billion backlog. Shares remain about 7.8% below the October 24 high. A new legal issue has emerged as Wall Street interest climbs.
Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks shares fell 2.5% to $84.91 on December 1 after agreeing to a $38.9 million New York City settlement over alleged violations of worker scheduling laws. The drop comes amid a nationwide union strike and split analyst views on the company’s outlook. Starbucks remains up 4.2% year-to-date but trades well below its 2021 peak.
Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

A U.S. federal judge allowed a $6.7 billion lawsuit against Bristol-Myers Squibb over its 2019 Celgene acquisition to proceed, rejecting the company’s motion to dismiss key claims. BMY shares closed at $49.18 on December 1, up 7–8% over five days, but remain down for the year. The company’s annual dividend yield is about 5%. New cell therapy approvals and strong ASH 2025 hematology data also drew investor attention.
Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont stock closed at $91.83 on December 1, 2025, more than doubling year-to-date after a 12% jump in November. UBS raised its price target to $125, citing strong gold prices and Newmont’s record free cash flow. The company posted Q3 net income of $1.8 billion and revenue of $5.52 billion, both beating estimates. Newmont has rapidly reduced debt and increased share buybacks.
2 December 2025
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health shares closed at $79.10 on December 1, 2025, down 1.6% and about 7% below their 52-week high. The stock is up nearly 79% year-to-date. Q3 revenue rose 7.8% to $102.9 billion, with adjusted EPS of $1.60 but a GAAP loss per share of –$3.13 due to a $5.7 billion non-cash goodwill impairment. CVS’s trailing P/E ratio spiked above 200 from the one-time charge.
CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group halted trading for about 10 hours on November 28 after a cooling failure at a CyrusOne data center in Illinois, disrupting global futures and options markets. Shares closed at $279, down 0.9%, with a market cap over $100 billion. CME stock is up about 21% year-to-date, but some analysts warn it may be overvalued by up to 40%. The company paid $10.80 per share in dividends over the past year.
2 December 2025
Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin closed December 1, 2025, at about $856 per share, with a $109 billion market cap. The stock is up roughly 36% year-to-date, beating the S&P 500. Growth is driven by strong aerospace results and the $9.25 billion Filtration Group acquisition. Some models now estimate PH is overvalued by about 30%, though most analysts remain positive.
1 December 2025
KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR shares closed near $122.50 on December 1, up from autumn lows but still 28% below the January peak of $170.40. The firm reported a strong Q3 earnings beat and faces new regulatory scrutiny as it joins the Bank of England’s private credit stress test. Market cap stands at about $108 billion. The next $0.19 dividend is set for December 2.
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare closed at about $503 on December 1, down 1% from Friday and just below its record high of $520 set in the prior session. Institutional investors shifted positions, with Dixon Mitchell raising its stake by 6.9% and others reducing holdings. The stock is up 71.5% year-to-date and trades at a discount to sector averages. Institutional holders control about 62.7% of shares.
1 December 2025
Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell closed at $190.22 on December 1, down 1% for the day and about 16% below its 52-week high. The company recently beat Q3 earnings estimates, raised full-year guidance, and completed the Solstice Advanced Materials spin-off. Bank of America double-downgraded the stock to Underperform, while most analysts still rate it a Buy. Honeywell plans to split into Aerospace and Automation firms by 2026.
Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo shares closed at $85.4 on December 1, 2025, down just over half a percent, after hitting a record $88.54 in November. The bank reported Q3 net income of $5.6 billion, up from $5.1 billion a year earlier, and raised its medium-term ROTCE target to 17–18% after the Fed lifted its asset cap. Market cap stands near $270 billion. December 1 marked both a dividend payout and an $85 million class-action settlement.
1 December 2025
Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon closed December 1, 2025, at $40–41 per share, with a $173 billion market cap and a 6.7–6.8% dividend yield. Third-quarter revenue reached $33.8 billion, up 1.5% year-over-year, while adjusted EPS was $1.21. Wireless service revenue rose to $21.0 billion. Total unsecured debt fell to $119.7 billion from $126.4 billion a year earlier.
Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific closed at $231.36 on December 1, 2025, valuing the company at $137 billion, with shares trading between $204.66 and $256.84 over the past year. Q3 adjusted EPS rose 12% to $3.08, net income climbed 9% to $1.8 billion, and operating revenue reached $6.24 billion. The company faces elevated regulatory and merger risk as it pursues an $85 billion Norfolk Southern deal.
Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments shares traded near $168 on December 1, 2025, valuing the company at about $152 billion, down roughly 10% year-to-date and 16% over 12 months. Q3 revenue rose 14% to $4.74 billion, beating estimates, but the stock remains below its 52-week high as investors weigh heavy spending and a softer earnings outlook.
Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron shares traded at $152–153 on Monday after HSBC upgraded the stock to Buy and raised its price target to $169. The move follows a drone attack on a key export terminal and renewed focus on Chevron’s 2030 free-cash-flow plan. CVX yields 4.4–4.6% with a $1.71 quarterly dividend, and has returned 10.6% year to date. Market cap stands near $300 billion.
1 December 2025
1 728 729 730 731 732 764

Stock Market Today

  • Investors Favor Google's AI Spending Over Meta Despite Both Raising Capex Guidance
    April 29, 2026, 10:00 PM EDT. Alphabet and Meta both reported strong first-quarter earnings, raising capital expenditure (capex) forecasts to fuel AI infrastructure. Alphabet's shares jumped 7% post-earnings, while Meta's dropped 7%, reflecting investor trust in Google's AI strategy. Alphabet's cloud division grew 63%, bolstering revenue by 20%, with a capex guidance raised to $180-$190 billion through 2026. Meta increased its capex forecast to $125-$145 billion, citing component costs and data center investments. Wall Street favors Alphabet's cloud-driven AI growth, contrasting with skepticism over Meta's AI investments tied primarily to advertising. Alphabet's stock is up 118% over the past year compared to Meta's 21%, underscoring the market's preference for sustainable AI revenue models.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop